查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1159156

比沙可啶的全球市場(2022年～2028年)

Bisacodyl Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

全球比沙可啶的市場規模在預測期間內預計將以5.9％的年複合成長率增長。便秘發生數量持續增加有助於市場增長。

本報告提供全球比沙可啶市場相關調查分析，提供市場概要，競爭情形，市場分析，企業簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • Cipla Ltd.
  • Dr Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC.
  • LGM Pharma LLC.
  • SANOFI
  • 主要策略分析
  • COVID-19對主要企業帶來的影響

第4章 市場區隔

  • 全球比沙可啶市場:各類型
    • 低純度
    • 高純度
  • 全球比沙可啶市場:各用途
    • 便秘
    • 神經性大腸功能障礙

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 全球其他地區

第6章 企業簡介

  • Adcock Ingram Ltd.
  • American Remedies Healthcare Pvt Ltd.
  • BDH industries Ltd.
  • Cambrex Corp.
  • Carbosynth Ltd.
  • Delvin Formulations Pvt. Ltd.
  • Healthy Life Pharma Ltd.
  • Heer Pharma Pvt. Ltd.
  • Kreative Organics Pvt.Ltd.
  • Medriech Ltd.
  • Shilpa Medicare Ltd.
  • UK vet chem.
  • Venkatasai life sciences
Product Code: OMR2025681

Global Bisacodyl Market Size, Share & Trends Analysis Report by Type ( High Purity and Low Purity), by Application (Constipation and Neurogenic Bowl Dysfunction) Forecast 2022-2028.

The global bisacodyl market is expected to grow at a significant CAGR of 5.9 % during the forecast period of 2022 -2028. Bisacodyl is used on a short-term basis to treat constipation. It is also used to empty the bowels before surgery and certain medical procedures bisacodyl is a class of medications called stimulant laxatives. It works by increasing the activity of the intestines to cause a bowel movement

The increasing incidences of constipation is contributing to the growth of the market. Abbott, one of India's largest healthcare firms, undertook a nationwide Gut Health Survey to analyze the status of constipation patients across the country, as well as the relationship between constipation and comorbidities including diabetes, hypothyroidism, and anorectal illnesses. According to the findings, 22% of the adult Indian population suffers from constipation, with 13% experiencing severe constipation. Constipation affects 6% of the Indian population, and it is linked to a number of comorbidities. The Gut Health Survey sheds light on the plight of these "silent patients," as well as the causes of chronic constipation and the issues that come with it. Abbott collaborated with IPSOS, a worldwide market research and consultancy business, to conduct a survey of 4,133 people in eight cities: Mumbai, Delhi, Kolkata, Hyderabad, Chennai, Patna, Ahmedabad, and Lucknow. The survey of eight cities found that metros (23 percent) have a higher percentage of constipation sufferers than non-metros (19%). With 28 % of sufferers, Kolkata leads the way, followed by Chennai with 26%.

The global bisacodyl market is segmented based on type and application. Based on the type, the market is segmented into high purity and low purity. Based on the application, the market is sub-segmented into constipation and Neurogenic bowel dysfunction. Chronic constipation can affect up to 20 % of the population and harms the quality of life and causes psychological stress. For instance, according to the National Center for Biotechnology Information, the annual health care costs are estimated at $ 821 million spent annually on over-the-counter laxatives and visit physicians. Therefore, due to the raising and prevailing growth of constipation and Neurogenic bowel dysfunction, there is a high usage of high purity and low purity bisacodyl drugs.

The major companies serving the global bisacodyl market include Cipla ltd., Dr.Reddy's Laboratories, GlaxoSmithKline plc, LMG Pharma, Sanofi S.A and others. The players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2021, Shilpa Medicare launched PRUCALSHIL, orally disintegrating strips of 1mg and 2 mg in India for the treatment of chronic constipation.

Research Methodology

The market study of the global bisacodyl market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Bisacodyl Market Research and Analysis by Type.

2. Global Bisacodyl Market Research and Analysis by Application

The Report Covers:

  • Comprehensive Research Methodology of the global bisacodyl market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global bisacodyl market.
  • Insights about market determinants that are stimulating the global bisacodyl market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global Bisacodyl Market
  • Recovery Scenario of Global Bisacodyl Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Cipla Ltd.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Dr Reddy's Laboratories Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GlaxoSmithKline PLC.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. LGM Pharma LLC.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. SANOFI
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Bisacodyl Market by Type
    • 4.1.1. Low Purity
    • 4.1.2. High Purity
  • 4.2. Global Bisacodyl Market by application
    • 4.2.1. Constipation
    • 4.2.2. Neurogenic Bowl Dysfunction

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Adcock Ingram Ltd.
  • 6.2. American Remedies Healthcare Pvt Ltd.
  • 6.3. BDH industries Ltd.
  • 6.4. Cambrex Corp.
  • 6.5. Carbosynth Ltd.
  • 6.6. Delvin Formulations Pvt. Ltd.
  • 6.7. Healthy Life Pharma Ltd.
  • 6.8. Heer Pharma Pvt. Ltd.
  • 6.9. Kreative Organics Pvt.Ltd.
  • 6.10. Medriech Ltd.
  • 6.11. Shilpa Medicare Ltd.
  • 6.12. UK vet chem.
  • 6.13. Venkatasai life sciences

LIST OF TABLES

  • 1. GLOBAL BISACODYL MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL LOW PURITY BISACODYL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL HIGH PURITY BISACODYL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL BISACODYL MARKETRESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 5. GLOBAL CONSTIPATION BISACODYL MARKETRESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL NEUROGENIC BOWEL DYSFUNCTION IN BISACODYL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL BISACODYL MARKETRESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 8. NORTH AMERICAN BISACODYL MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 9. NORTH AMERICAN BISACODYL MARKETRESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 10. NORTH AMERICAN BISACODYL MARKETRESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 11. EUROPEAN BISACODYL MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 12. EUROPEAN BISACODYL MARKETRESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 13. EUROPEAN BISACODYL MARKETRESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 14. ASIA-PACIFIC BISACODYL MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 15. ASIA-PACIFIC BISACODYL MARKETRESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 16. ASIA-PACIFIC BISACODYL MARKETRESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 17. REST OF THE WORLD BISACODYL MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. REST OF THE WORLD BISACODYL MARKETRESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 19. REST OF THE WORLD BISACODYL MARKETRESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL BISACODYL MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL BISACODYL MARKETBY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL BISACODYL MARKET, 2021-2027 (%)
  • 4. GLOBAL BISACODYL MARKETSHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL HIGH PURITY BISACODYL MARKETSHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL LOW PURITY BISACODYL MARKETSHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL BISACODYL MARKETSHARE BY APPLICATION, 2021 VS 2028 (%)
  • 8. GLOBAL CONSTIPATION BISACODYL MARKETSHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL NEUROGENIC BOWEL DYSFUNCTION IN BISACODYL MARKETSHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL BISACODYL MARKETSHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 11. US BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 12. CANADA BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 13. UK BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 14. FRANCE BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 15. GERMANY BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 16. ITALY BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 17. SPAIN BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 18. REST OF EUROPE BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 19. INDIA BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 20. CHINA BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 21. JAPAN BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 22. SOUTH KOREA BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)
  • 24. REST OF THE WORLD BISACODYL MARKETSIZE, 2021-2028 ($ MILLION)